Personalized at-home neurofeedback compared with long-acting methylphenidate in an european non-inferiority randomized trial in children with ADHD

被引:20
|
作者
Bioulac, Stephanie [1 ,2 ,3 ]
Purper-Ouakil, Diane [4 ]
Ross, Tomas [5 ]
Blasco-Fontecilla, Hilario [6 ,7 ]
Prats, Marie [8 ]
Mayaud, Louis [8 ]
Brandeis, Daniel [9 ,10 ,11 ]
机构
[1] CHU Pellegrin, Clin Sommeil, F-33076 Bordeaux, France
[2] Univ Bordeaux, Sommeil Addict & Neuropsychiat, USR 3413, F-33000 Bordeaux, France
[3] CNRS, SANPSY, USR 3413, F-33000 Bordeaux, France
[4] CHU Montpellier St Eloi Hosp, Unit Child & Adolescent Psychiat MPEA1, Montpellier, France
[5] Univ Geneva, Dept Neurosci, Lab Neurol & Imaging Cognit, Geneva, Switzerland
[6] Puerta de Hierro Univ Hosp, Segovia de Arana Hlth Res Inst IDIPHISA, Dept Psychiat, Ave Manuel Falla S-N, Madrid, Spain
[7] Univ Autonoma Madrid, Madrid, Spain
[8] Mensia Technol, 130 Rue Lourmel, F-75015 Paris, France
[9] Univ Zurich, Zurich, Switzerland
[10] Swiss Fed Inst Technol, Neurosci Ctr Zurich, Zurich, Switzerland
[11] Heidelberg Univ, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Med Fac Mannheim, Mannheim, Germany
关键词
Attention deficit hyperactivity disorder; Neurofeedback; Methylphenidate; Clinical trial; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; DIFFICULTIES QUESTIONNAIRE; VALIDITY; SCALE; EEG; BRAIN; CONSISTENCY; ANNOTATION; VALIDATION;
D O I
10.1186/s12888-019-2218-0
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundNeurofeedback (NF) has gained increasing interest among non-pharmacological treatments for Attention Deficit Hyperactivity Disorder (ADHD). NF training aims to enhance self-regulation of brain activities. The goal of the NEWROFEED study is to assess the efficacy of a new personalized NF training device, using two different protocols according to each child's electroencephalographic pattern, and designed for use at home. This study is a non-inferiority trial comparing NF to methylphenidate.MethodsThe study is a prospective, multicentre, randomized, reference drug-controlled trial. One hundred seventy-nine children with ADHD, aged 7 to 13years will be recruited in 13 clinical centres from 5 European countries. Subjects will be randomized to two groups: NF group (Neurofeedback Training Group) and MPH group (Methylphenidate group). Outcome measures include clinicians, parents and teachers' assessments, attention measures and quantitative EEG (qEEG). Patients undergo eight visits over a three-month period: pre-inclusion visit, inclusion visit, 4 discovery (NF group) or titration visits (MPH group), an intermediate and a final visit. Patients will be randomized to either the MPH or NF group. Children in the NF group will undergo either an SMR or a Theta/Beta training protocol according to their baselineTheta/Beta Ratio obtained from the qEEG.DiscussionThis is the first non-inferiority study between a personalized NF device and pharmacological treatment. Innovative aspects of Mensia Koala (TM) include the personalization of the training protocol according to initial qEEG characteristics (SMR or Theta/Beta training protocols) and an improved accessibility of NF due to the opportunity to train at home with monitoring by the clinician through a dedicated web portal.Trial registrationNCT02778360. Date registration (retrospectively registered): 5-12-2016. Registered May 19, 2016
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
    Kityo, Cissy
    Mambule, Ivan K.
    Musaazi, Joseph
    Sokhela, Simiso
    Mugerwa, Henry
    Ategeka, Gilbert
    Cresswell, Fiona
    Siika, Abraham
    Kosgei, Josphat
    Shah, Reena
    Naidoo, Logashvari
    Opiyo, Kimton
    Otike, Caroline
    Moller, Karlien
    Kaimal, Arvind
    Wambui, Charity
    Van Eygen, Veerle
    Mohammed, Perry
    Boateng, Fafa Addo
    Paton, Nicholas, I
    LANCET INFECTIOUS DISEASES, 2024, 24 (10): : 1083 - 1092
  • [42] Evaluation of the analgesic efficacy of grapiprant compared with robenacoxib in cats undergoing elective ovariohysterectomy in a prospective, randomized, masked, non-inferiority clinical trial
    Pisack, Elizabeth K.
    Kleine, Stephanie A.
    Hampton, Chiara E.
    Smith, Christopher K.
    Weisent, Jennifer
    DeBolt, Rebecca
    Schumacher, Cambrie
    Bussieres, Genevieve
    Seddighi, Reza
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2024, 26 (03)
  • [43] Efficacy of continuous passive motion compared to physiotherapy in rehabilitation after total knee replacement: a prospective randomized controlled non-inferiority trial
    Schroter, Johannes
    Renz, Julian
    Raisig, Natascha
    Schuller, Per Otto
    Afghanyar, Yama
    Arand, Charlotte
    Nienhaus, Michael
    Gercek, Erol
    INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2024, 47 (04) : 246 - 251
  • [44] Popliteal plexus block compared with tibial nerve block on rehabilitation goals following total knee arthroplasty: a randomized non-inferiority trial
    Sakai, Norihiro
    Adachi, Takamasa
    Sudani, Tomoko
    Taruishi, Chieko
    Uematsu, Yuki
    Takada, Motoshi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [45] A randomized controlled trial of return of genomic results shows non-inferiority of web-based compared to counselor return of carrier results
    Biesecker, L. G.
    Lewis, K.
    Umstead, K.
    Johnston, J.
    Biesecker, B.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 806 - 806
  • [46] PALIPERIDONE PALMITATE 6-MONTH LONG-ACTING INJECTABLE FOR SCHIZOPHRENIA: A RANDOMISED, DOUBLE-BLIND, MULTICENTER, NON-INFERIORITY PHASE 3 STUDY
    Liu, D.
    Najarian, D.
    Sanga, P.
    Wang, S.
    Lim, P.
    Singh, A.
    Robertson, M. J.
    Cohen, K.
    Schotte, A.
    Milz, R.
    Venkatasubramanian, R.
    T'Jollyn, H.
    Walling, D. P.
    Galderisi, S.
    Gopal, S.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (1_SUPPL): : 220 - 220
  • [47] Pyronaridine–artesunate and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial
    Johanna M. Roth
    Patrick Sawa
    Nicodemus Makio
    George Omweri
    Victor Osoti
    Selpha Okach
    Felix Choy
    Henk D. F. H. Schallig
    Pètra Mens
    Malaria Journal, 17
  • [48] Correction to: Virtual reality hypnosis for needle-related procedural pain and fear management in children: a non-inferiority randomized trial
    Sharron van den Berg
    Maurits O. Hoogeveen
    Tijn M. S. van Winden
    Malika Chegary
    Mehmet S. Genco
    Nini H. Jonkman
    European Journal of Pediatrics, 2023, 182 : 4431 - 4431
  • [49] Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children
    Emily M. Teshome
    Pauline E. A. Andang’o
    Victor Osoti
    Sofie R. Terwel
    Walter Otieno
    Ayşe Y. Demir
    Andrew M. Prentice
    Hans Verhoef
    BMC Medicine, 15
  • [50] Daily home fortification with iron as ferrous fumarate versus NaFeEDTA: a randomised, placebo-controlled, non-inferiority trial in Kenyan children
    Teshome, Emily M.
    Andang'o, Pauline E. A.
    Osoti, Victor
    Terwel, Sofie R.
    Otieno, Walter
    Demir, Ayse Y.
    Prentice, Andrew M.
    Verhoef, Hans
    BMC MEDICINE, 2017, 15